VESUGEN

Part of the Khavinson bioregulator family, this tripeptide consists of three amino acids (lysine-glutamate-aspartate) and targets vascular endothelial cells specifically. Cardiovascular researchers investigate it primarily for its potential role in maintaining blood vessel health during aging processes. The peptide represents one of several organ-specific bioregulators developed through decades of Russian gerontology research.

The tripeptide appears to bind directly to specific DNA sequences within vascular endothelial cells, acting like a molecular switch that can turn certain genes on or off. This genetic modulation potentially influences how blood vessels form new branches, repair damage, and regulate blood flow. Think of it as a targeted instruction set that helps aging blood vessels remember how to maintain themselves properly.